Long-Term Seizure Outcomes in Autoimmune Encephalitis
Nearly one-third of patients with AE and acute seizures developed treatment-resistant postencephalitic epilepsy, with significant predictors including absence of focal slowing on acute EEG, presence of IEDs and PDs on subacute EEG, absence of cell surface antibodies, and absence of early immunotherapy treatment of patients with positive neural antibodies.
Authors
- Maria Pleshkevich (ORCID: https://orcid.org/0000-0002-4888-2415)
- Yifei Sun (ORCID: https://orcid.org/0000-0002-2321-4795)
- Kiran T. Thakur (ORCID: https://orcid.org/0000-0003-0050-0323)
- Carla Y. Kim (ORCID: https://orcid.org/0000-0001-5714-7212)
- Julien Hébert (ORCID: https://orcid.org/0000-0003-3390-9192)
- Claude Steriade (ORCID: https://orcid.org/0000-0001-6799-9005)
- Lucy Jia
- Rosa R. Cui
Institutions
- NewYork–Presbyterian Hospital (US)
- University of Toronto (CA)
- New York Hospital Queens (US)
- NYU Langone Health (US)
- Columbia University (US)
Publication Details
- Journal
- The Neurohospitalist
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1177/19418744251331650
- Citations
- 5
- Primary Topic
- Autoimmune Neurological Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 6.95
Funders
- Clinical and Translational Science Institute, New York University
- National Institute of Neurological Disorders and Stroke